A Novel LMNA Mutation Causes Altered Nuclear Morphology and Symptoms of Familial Partial Lipodystrophy (Dunnigan Variety) with Progeroid Features
Related Experiment Video
Updated: Jun 7, 2026

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
Published on: January 17, 2025
1Department of Pathology, University of Washington, Seattle, Wash., USA.
Abstract:
Dunnigan-type partial lipodystrophy (familial partial lipodystrophy, Dunnigan variety, FPLD2) can be caused by LMNA mutations. We identified a novel heterozygous LMNA mutation, P485R, in a patient referred to the International Registry of Werner Syndrome because of features consistent with that of progeroid disorder but who was wild type at the WRN locus. The novel mutation is located 2 amino acids away from the canonical FPLD mutations in exon 8 of the LMNA gene. Immunocytochemical analysis revealed abnormal nuclear morphology characteristic of laminopathies within primary fibroblast cultures, but not in a lymphoblastoid cell line, in keeping with previous observations. Our findings indicate that FPLD2 should be considered in the differential diagnosis of the Werner syndrome.
Insights
Familial partial lipodystrophy type 2 (FPLD2), caused by LMNA mutations, should be considered in Werner syndrome diagnoses. A novel LMNA mutation, P485R, was identified in a patient with progeroid features.
Area of Science:
- Genetics
- Molecular Biology
- Endocrinology
Background:
- Dunnigan-type partial lipodystrophy (FPLD2) is a genetic disorder often caused by mutations in the LMNA gene.
- Progeroid syndromes, like Werner syndrome, share some clinical features with lipodystrophies, complicating diagnosis.
Purpose of the Study:
- To investigate a potential novel genetic cause of FPLD2 in a patient presenting with Werner syndrome-like features.
- To analyze the pathogenicity of a newly identified LMNA mutation.
Main Methods:
- Genetic sequencing to identify mutations in the LMNA and WRN genes.
- Immunocytochemical analysis of primary fibroblast and lymphoblastoid cell lines to assess nuclear morphology.
Main Results:
- A novel heterozygous LMNA mutation, P485R, was identified in a patient with progeroid features who was wild type for the WRN gene.
- The mutation is located near canonical FPLD2 mutations in exon 8 of LMNA.
- Abnormal nuclear morphology, indicative of laminopathy, was observed in patient-derived fibroblasts but not in lymphoblastoid cells.
Conclusions:
- The novel LMNA mutation P485R is associated with Dunnigan-type partial lipodystrophy (FPLD2).
- FPLD2 should be included in the differential diagnosis for patients presenting with features of Werner syndrome.
- Cell-type-specific effects of laminopathies may influence diagnostic findings.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Alzheimer Disease l: Introduction
Abnormal Proliferation
Huntington Disease l: Introduction
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...

